During the past decade, Central Indiana Cancer Centers conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 38 clinical trials were completed, i.e. on average, 475% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 11 clinical trials were completed. i.e. 1100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Central Indiana Cancer Centers" #1 sponsor was "Radiation Therapy Oncology Group" with 14 trials, followed by "NSABP Foundation Inc" with 10 trials sponsored, "US Oncology Research" with 8 trials sponsored, "Celgene" with 4 trials sponsored and "Eisai Inc." with 4 trials sponsored. Other sponsors include 37 different institutions and companies that sponsored additional 39 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Central Indiana Cancer Centers" #1 collaborator was "National Cancer Institute (NCI)" with 28 trials as a collaborator, "Hoosier Cancer Research Network" with 11 trials as a collaborator, "NRG Oncology" with 9 trials as a collaborator, "Eli Lilly and Company" with 5 trials as a collaborator and "Bristol-Myers Squibb" with 4 trials as a collaborator. Other collaborators include 31 different institutions and companies that were collaborators in the rest 32 trials.

According to Clinical.Site data, the most researched conditions in "Central Indiana Cancer Centers" are "Breast Cancer" (15 trials), "Prostate Cancer" (9 trials), "Leukemia" (5 trials), "Urothelial Carcinoma" (5 trials) and "Non-Small Cell Lung Cancer" (4 trials). Many other conditions were trialed in "Central Indiana Cancer Centers" in a lesser frequency.

Most popular intervention types in "Central Indiana Cancer Centers" are "Drug" (74 trials), "Radiation" (16 trials), "Procedure" (6 trials), "Biological" (3 trials) and "Dietary Supplement" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (7 trials), "cyclophosphamide" (7 trials), "radiation therapy" (6 trials), "Docetaxel" (5 trials) and "Prednisone" (4 trials). Other intervention names were less common.

The vast majority of trials in "Central Indiana Cancer Centers" are 54 trials for "All" genders, 17 trials for "Female" genders and 10 trials for "Male" genders.

Currently, there are NaN active trials in "Central Indiana Cancer Centers". undefined are not yet recruiting, undefined are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 63 completed trials in Central Indiana Cancer Centers, undefined suspended trials, and 13 terminated clinical trials to date.

Out of the total trials that were conducted in Central Indiana Cancer Centers, 12 "Phase 1" clinical trials were conducted, 37 "Phase 2" clinical trials and 38 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".